Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate governance
    • Contact

    Financial Information

    Financial Information

    Show all

    2023

    Q3
    • Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update

    Annual Reports

    2022 Annual Report
    2021 Annual Report

    Proxy Statements

    2022 Proxy Statement
    2021 Proxy Statement

    Form 10-K

    Filing date View
    Mar 30, 2023 View HTML
    0001401914-23-000013.pdf
    0001401914-23-000013.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    Mar 31, 2022 View HTML
    0001401914-22-000032.pdf
    0001401914-22-000032.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

    Form 10-Q

    Filing date View
    Nov 09, 2023
    0001401914-23-000048.pdf
    0001401914-23-000048.rtf
    0001401914-23-000048.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
    Aug 10, 2023
    0001401914-23-000045.pdf
    0001401914-23-000045.rtf
    0001401914-23-000045.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top